A new drug that will help smokers quit the market in Canada by the end of April. The Canadian Ministry of Health has approved a new generation of smoking cessation drugs that are different from all types
The drug is currently available in this market.
According to the pharmaceutical company Pfizer, the new drug produced by the manufacturer called Champix, a varenicline tartrate compound has proven to be twice as effective as Zyban.
Unlike other high-quality drugs that penetrate the skin, Champix does not release nicotine into the body. Dr. Gaston Ostiguy, a lung specialist at Montreal Thoracic Institute explained that this drug affects the nicotine sensing cells that smokers have developed in the brain. When activated, these sensory cells secrete dopamine, creating a pleasant feeling.
VN
